(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol

C36H46N2O7S — CID 67496079

IUPAC(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](O)[C@@H]3c3ccc(COCC4CC4)cc3)cc21
InChIInChI=1S/C36H46N2O7S/c1-26-4-13-31(14-5-26)46(40,41)38-21-33(39)36(30-11-8-28(9-12-30)24-43-23-27-6-7-27)35(22-38)45-25-29-10-15-34-32(20-29)37(17-19-44-34)16-3-18-42-2/h4-5,8-15,20,27,33,35-36,39H,3,6-7,16-19,21-25H2,1-2H3/t33-,35+,36+/m1/s1
InChIKeyPEJOKKPVGZGPDR-YGIRKPQBSA-N
MW650.84 g/mol
LogP4.89
Rot. Bonds14

About (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol

(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol (PubChem CID 67496079) has the molecular formula C36H46N2O7S and a molecular weight of 650.84 g/mol. Its IUPAC name is (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol.

Molecular Properties

Compound Name(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol
PubChem CID67496079
Molecular FormulaC36H46N2O7S
Molecular Weight650.84 g/mol
Exact Mass650.30
IUPAC Name(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](O)[C@@H]3c3ccc(COCC4CC4)cc3)cc21
InChIInChI=1S/C36H46N2O7S/c1-26-4-13-31(14-5-26)46(40,41)38-21-33(39)36(30-11-8-28(9-12-30)24-43-23-27-6-7-27)35(22-38)45-25-29-10-15-34-32(20-29)37(17-19-44-34)16-3-18-42-2/h4-5,8-15,20,27,33,35-36,39H,3,6-7,16-19,21-25H2,1-2H3/t33-,35+,36+/m1/s1
InChIKeyPEJOKKPVGZGPDR-YGIRKPQBSA-N
XLogP4.89
TPSA97.77 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds14
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500650.84
LogP ≤ 54.89
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol?
The IUPAC name of (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol (CID 67496079) is (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol.
What is the SMILES notation for (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol?
The canonical SMILES for (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol is COCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](O)[C@@H]3c3ccc(COCC4CC4)cc3)cc21.
What is the InChIKey of (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol?
The InChIKey is PEJOKKPVGZGPDR-YGIRKPQBSA-N. The full InChI is InChI=1S/C36H46N2O7S/c1-26-4-13-31(14-5-26)46(40,41)38-21-33(39)36(30-11-8-28(9-12-30)24-43-23-27-6-7-27)35(22-38)45-25-29-10-15-34-32(20-29)37(17-19-44-34)16-3-18-42-2/h4-5,8-15,20,27,33,35-36,39H,3,6-7,16-19,21-25H2,1-2H3/t33-,35+,36+/m1/s1.
What are the key properties of (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol?
(3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol has a molecular weight of 650.84 g/mol, XLogP of 4.89, 14 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,4S,5R)-4-[4-(cyclopropylmethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-ol is sourced from PubChem (CID 67496079), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).